Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Accenture Crashes Most On Record As AI Threatens Consulting Demand

% of readers think this story is Fact. Add your two cents.


Accenture Crashes Most On Record As AI Threatens Consulting Demand

Accenture shares crashed by the most on record in premarket trading on a confluence of issues. First, the company’s fourth-quarter revenue outlook missed Bloomberg consensus estimates and third-quarter bookings declined, reinforcing investors’ belief that consulting demand is declining in the era of AI adoption across corporate America, which is wreaking havoc in the white-collar job market.

The global consulting and technology services company, which helps large corporations and governments with strategy, IT, cloud migration, cybersecurity, and more, guided August-quarter revenue to a range of $17.75 billion to $18.4 billion, below the $18.47 billion figure that analysts tracked by Bloomberg were forecasting. Third-quarter bookings fell to $19.3 billion, down from $19.7 billion a year earlier, while revenue rose to $18.7 billion, slightly below estimates. EPS increased 9% to $3.80.

Here’s a snapshot of 3Q earnings, courtesy of Bloomberg:

EPS $3.80 vs. $3.49 y/y

Revenue $18.7 billion, +5.6% y/y, estimate $18.76 billion

  • Communications, Media & Technology revenue $3.22 billion, +10% y/y, estimate $3.2 billion
  • Financial Services revenue $3.49 billion, +6.4% y/y, estimate $3.54 billion
  • Product revenue $5.67 billion, +6.1% y/y, estimate $5.67 billion

Health & Public Service revenue $3.85 billion, +1.8% y/y, estimate $3.82 billion

  • Resources revenue $2.50 billion, +3.4% y/y, estimate $2.54 billion

Bookings $19.32 billion, -1.9% y/y, estimate $20.66 billion

  • Consulting new bookings $10.26 billion, +13% y/y, estimate $9.54 billion
  • Managed Services new bookings $9.06 billion, -15% y/y, estimate $11.12 billion

Gross margin 32.8% vs. 32.9% y/y, estimate 32.9%

Free cash flow $3.60 billion, +2.9% y/y

Operating cash flow $3.79 billion, +2.8% y/y, estimate $3.06 billion

Snapshot of 4Q forecast:

Sees revenue $17.75 billion to $18.4 billion, estimate $18.47 billion (Bloomberg Consensus)

Sees revenue +1% to +5%

Full-Year Forecast:

Sees revenue +3% to +4%, saw +3% to +5%

Sees adjusted EPS $13.78 to $13.90, saw $13.65 to $13.90

Sees effective tax rate 24% to 25%, saw 23.5% to 25.5%

Still sees operating cash flow $11.5 billion to $12.2 billion

Still sees free cash flow $10.8 billion to $11.5 billion

Beyond earnings, one major issue plaguing Accenture is investor confidence in the business model. Morgan Stanley downgraded Accenture to Equal-weight from Overweight and slashed its price target to $177 from $240, arguing that the anticipated boost to IT services spending from artificial intelligence investments has yet to materialize, as enterprises continue to prioritize AI projects over traditional discretionary technology spending.

Crucially, “we are not seeing the budget growth inflection we had previously expected,” the analysts wrote.

Morgan Stanley is not the first to sound the alarm on declining IT consulting demand. In March, Jefferies analyst Surinder Thind told clients there was limited evidence of a recovery in customer appetite, directly contradicting management’s upbeat commentary.

Accenture shares crashed the most on record, down 16% in the early cash session. 

What goes up must go down. 

Emergence of OpenAI’s ChatGPT (news headlines) vs. ACN stock price. 

According to Bloomberg data, Wall Street analysts have 17 “Buy” ratings, 12 “Neutral” ratings, and zero “Sell” ratings on the stock. The 12-month average price target is $236.

Thind called the latest earnings disappointing. “Questions around the resiliency of demand in an AI-first world are likely to be amplified,” he said, adding, “especially in light of recent advancements in AI models and agentic capabilities.”

Tyler Durden Thu, 06/18/2026 – 10:10


Source: https://freedombunker.com/2026/06/18/accenture-crashes-most-on-record-as-ai-threatens-consulting-demand/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login